BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 8733007)

  • 1. Mineralocorticoids, salt, hypertension: effects on the heart.
    Young MJ; Funder JW
    Steroids; 1996 Apr; 61(4):233-5. PubMed ID: 8733007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of cardiac fibrosis in experimental hypermineralocorticoid states.
    Young M; Head G; Funder J
    Am J Physiol; 1995 Oct; 269(4 Pt 1):E657-62. PubMed ID: 7485478
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy.
    Takeda Y; Yoneda T; Demura M; Usukura M; Mabuchi H
    Circulation; 2002 Feb; 105(6):677-9. PubMed ID: 11839620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoids and cardiac fibrosis: the decade in review.
    Funder J
    Clin Exp Pharmacol Physiol; 2001 Dec; 28(12):1002-6. PubMed ID: 11903303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of cardiac fibrosis by aldosterone.
    Lijnen P; Petrov V
    J Mol Cell Cardiol; 2000 Jun; 32(6):865-79. PubMed ID: 10888242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mineralocorticoid receptors and hypertension.
    Funder JW
    J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):53-5. PubMed ID: 7626506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of aldosterone and angiotensin II receptor blockade on cardiac angiotensinogen and angiotensin-converting enzyme 2 expression in Dahl salt-sensitive hypertensive rats.
    Takeda Y; Zhu A; Yoneda T; Usukura M; Takata H; Yamagishi M
    Am J Hypertens; 2007 Oct; 20(10):1119-24. PubMed ID: 17903697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of salt status and blockade of mineralocorticoid receptors on aldosterone-induced cardiac injury.
    Hattori T; Murase T; Sugiura Y; Nagasawa K; Takahashi K; Ohtake M; Ohtake M; Miyachi M; Murohara T; Nagata K
    Hypertens Res; 2014 Feb; 37(2):125-33. PubMed ID: 24048492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Respective role of humoral factors and blood pressure in cardiac remodeling of DOCA hypertensive rats.
    Karam H; Heudes D; Hess P; Gonzales MF; Löffler BM; Clozel M; Clozel JP
    Cardiovasc Res; 1996 Feb; 31(2):287-95. PubMed ID: 8730406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aldosterone, salt and cardiac fibrosis.
    Funder JW
    Clin Exp Hypertens; 1997; 19(5-6):885-99. PubMed ID: 9247762
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Myocardial fibrosis in the rat with mineralocorticoid excess. Prevention of scarring by amiloride.
    Campbell SE; Janicki JS; Matsubara BB; Weber KT
    Am J Hypertens; 1993 Jun; 6(6 Pt 1):487-95. PubMed ID: 8343231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mineralocorticoid receptor blockade attenuates chronic overexpression of the renin-angiotensin-aldosterone system stimulation of reduced nicotinamide adenine dinucleotide phosphate oxidase and cardiac remodeling.
    Stas S; Whaley-Connell A; Habibi J; Appesh L; Hayden MR; Karuparthi PR; Qazi M; Morris EM; Cooper SA; Link CD; Stump C; Hay M; Ferrario C; Sowers JR
    Endocrinology; 2007 Aug; 148(8):3773-80. PubMed ID: 17494996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
    Bos R; Mougenot N; Findji L; Médiani O; Vanhoutte PM; Lechat P
    J Cardiovasc Pharmacol; 2005 Jan; 45(1):8-13. PubMed ID: 15613973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mineralocorticoids, salt and high blood pressure.
    Gómez-Sánchez EP; Zhou M; Gomez-Sanchez CE
    Steroids; 1996 Apr; 61(4):184-8. PubMed ID: 8732997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.
    Nagata K; Obata K; Xu J; Ichihara S; Noda A; Kimata H; Kato T; Izawa H; Murohara T; Yokota M
    Hypertension; 2006 Apr; 47(4):656-64. PubMed ID: 16505208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reactive and reparative myocardial fibrosis in arterial hypertension in the rat.
    Brilla CG; Weber KT
    Cardiovasc Res; 1992 Jul; 26(7):671-7. PubMed ID: 1423431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The renin-angiotensin-aldosterone system in experimental mineralocorticoid-salt-induced cardiac fibrosis.
    Young MJ; Funder JW
    Am J Physiol; 1996 Nov; 271(5 Pt 1):E883-8. PubMed ID: 8944676
    [No Abstract]   [Full Text] [Related]  

  • 18. Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.
    Brilla CG; Zhou G; Matsubara L; Weber KT
    J Mol Cell Cardiol; 1994 Jul; 26(7):809-20. PubMed ID: 7966349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of aldosterone in angiotensin II-induced cardiac and aortic inflammation, fibrosis, and hypertrophy.
    Neves MF; Amiri F; Virdis A; Diep QN; Schiffrin EL;
    Can J Physiol Pharmacol; 2005 Nov; 83(11):999-1006. PubMed ID: 16391708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fadrozole reverses cardiac fibrosis in spontaneously hypertensive heart failure rats: discordant enantioselectivity versus reduction of plasma aldosterone.
    Minnaard-Huiban M; Emmen JM; Roumen L; Beugels IP; Cohuet GM; van Essen H; Ruijters E; Pieterse K; Hilbers PA; Ottenheijm HC; Plate R; de Gooyer ME; Smits JF; Hermans JJ
    Endocrinology; 2008 Jan; 149(1):28-31. PubMed ID: 17884944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.